Emflaza

Deflazacort

Emflaza is a corticosteroid indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients at the age of 5 and older.
more
Package Per pill Price Savings Order
180 tablet
R 13.86
R 2494.29R 13.86
R 4409.87
120 tablet
R 15.99
R 1918.46R 15.99
R 2684.31
90 tablet
R 19.18
R 1726.52R 19.18
R 1725.56
60 tablet
R 23.98
R 1438.61R 23.98
R 862.78
30 tablet
R 38.36
R 1150.69R 38.36
Package Per pill Price Savings Order
120 tablet
Free AirMail shipping Hot
R 87.97
R 10555.85R 87.97
R 1915.58
90 tablet
Free AirMail shipping Hot
R 92.76
R 8348.52R 92.76
R 1005.06
60 tablet
Free AirMail shipping Hot
R 95.96
R 5757.30R 95.96
R 478.42
36 tablet
Free AirMail shipping Hot
R 101.28
R 3645.94R 101.28
R 95.49
24 tablet
R 103.93
R 2494.29R 103.93
Package Per pill Price Savings Order
90 tablet
Free AirMail shipping Hot
R 106.62
R 9596.14R 106.62
R 1916.78
60 tablet
Free AirMail shipping Hot
R 115.15
R 6908.95R 115.15
R 766.33
36 tablet
Free AirMail shipping Hot
R 122.60
R 4413.71R 122.60
R 191.46
24 tablet
Free AirMail shipping Hot
R 127.92
R 3070.11R 127.92
Emflaza

Brand(s)

Manufacturer

  • Lupin

Disease(s)

  • Duchenne Muscular Dystrophy / DMD

Deflazacort tablets

What is this medicine?

Deflazacort a corticosteroid indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 5 years of age and older.

What should I tell my health care providers before I take this medicine?

They need to know if you have any of these conditions:

  • Hypersensitivity to deflazacort;
  • Alterations in Endocrine Function: Hypothalamic-pituitary-adrenal axis suppression, Cushing’s syndrome, and hyperglycemia;
  • Immunosuppression and Increased Risk of Infection: Increased risk of new, exacerbation, dissemination, or reactivation of latent infections, which can be severe and at times fatal;
  • Alterations in Cardiovascular/Renal Function: elevated blood pressure and sodium, and for decreased potassium level;
  • Gastrointestinal Perforation: GI disorders;
  • Behavioral and Mood Disturbances: euphoria, insomnia, mood swings, personality changes, severe depression, and psychosis;
  • Effects on Bones: decreases in bone mineral density;
  • Serious Skin Rashes;
  • Ophthalmic Effects: May include cataracts, infections, and glaucoma;
  • Vaccination: Do not administer live or live attenuated vaccines to patients receiving immunosuppressive doses of corticosteroids.

How should I use this medicine?

The recommended once-daily dosage is approximately 0.9 mg/kg/day administered orally. Discontinue gradually when administered for more than a few day..

What may interact with this medicine?

  • Moderate or strong CYP3A4 inhibitors: Give one third of the recommended dosage;
  • Avoid use of moderate or strong CYP3A4 inducers, as they may reduce efficacy.

What side effects may I notice from this medicine?

The most common adverse reactions are Cushingoid appearance, weight increased, increased appetite, upper respiratory tract infection, cough, pollakiuria, hirsutism, central obesity, and nasopharyngitis.